Browsing Tag
biotechnology intellectual property
2 posts
A single appeals court ruling puts gene therapy patent economics back in play for Regenxbio Inc. and Sarepta Therapeutics Inc.
Regenxbio Inc. wins a key appeals court reversal against Sarepta Therapeutics Inc. Discover what this means for gene therapy IP and investors.
PDS Biotechnology Corporation strengthens PDS0101 intellectual property ahead of key regulatory milestones
PDS Biotechnology strengthens PDS0101 patent protection ahead of key Phase 3 and regulatory milestones. Find out what this means for investors.